The influence of USA risk evaluation and mitigation strategy on the reference listed drug of generic product in China
YANG Dong-sheng
NIU Jian-zhao
XU Ming-di
Machine-generated Keywords：
Publication Date：2021-05-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：7( 784-790 )